revascularization

Eisai Signs Collaboration Agreement for Anti-Obesity Agent Lorcaserin in China to CY Biotech

Tokyo, August 04, 2018: Eisai Co., Ltd. announced today that it has entered into an agreement to grant exclusive development…

6 years ago